By CrossBorder IP · Published October 20, 2026
For international founders, inventors, and companies, the US patent system used to allow something most other major patent offices did not: you could file and prosecute your own US application from anywhere in the world. That is over. Under the USPTO foreign applicant rule that took effect on July 20, 2026, patent applicants and patent owners domiciled outside the United States must be represented by a USPTO-registered patent practitioner.
The rule matters most for international startups, research groups, and smaller companies that have been handling US filings in-house or through a home-country attorney who is not registered in the US. It also catches some situations that surprise even sophisticated filers. Here is how it works and what to do about it.
The USPTO published the final rule in the Federal Register on March 20, 2026, with a 120-day runway to the July 20 effective date. From that date, papers in patent matters filed on behalf of a foreign-domiciled applicant or patent owner must be signed by a registered US patent attorney or agent.
The rule applies to papers received on or after July 20, 2026, regardless of when the application was filed or the patent issued. A foreign applicant who filed pro se in 2024 now needs a registered practitioner to respond to the next Office action in that same application.
The USPTO’s stated reasons include harmonising US practice with other offices that already require local representation, reducing the resources spent assisting self-represented applicants, and deterring fraud, such as false fee-status certifications. The rule parallels the requirement the USPTO introduced for foreign-domiciled trademark applicants in 2019.
Domicile, not citizenship or mailing address, is the test. For an individual, it is the place of permanent legal residence; for a company, its principal place of business. That produces some outcomes worth knowing:
A foreign-domiciled applicant can still obtain a filing date if the basic requirements are met, so the rule does not immediately stop you getting into the system. The risk lies in what happens next. Papers not properly signed may not be effective, and several critical elements may not be recognised unless signed by a registered practitioner, including:
Any of these can quietly undermine an application, and a missed response deadline can lead to abandonment. For companies whose valuation depends on a US patent family, these are not administrative details.
Pro tip: The priority claim is the one to protect above all. If your US filing relies on a home-country or PCT first filing, make sure the claim is properly made and signed. As the Federal Circuit’s August 2026 Dental Monitoring decision shows, priority dates are increasingly scrutinised — see Is Your Provisional Patent Application Strong Enough?.
| Situation | Risk level | Action |
|---|---|---|
| Foreign startup prosecuting US applications pro se | High | Appoint a registered US practitioner before the next deadline |
| Home-country attorney filing directly at the USPTO but not US-registered | High | Engage a registered US practitioner to sign and file |
| US company with a foreign co-applicant (university, JV partner) | Medium | Confirm representation covers the whole application |
| Founder who relocated abroad but still owns patents personally | Medium | Check domicile and appoint representation for post-issuance filings |
| Foreign company already using US counsel for all filings | Low | Confirm powers of attorney and correspondence addresses are current |
For cross-border companies, ownership records are as important as prosecution. On September 22, 2026, the USPTO announced it will participate in the World Intellectual Property Organization’s pilot of a Global IP Assignment Platform — a centralised, standardised system for filing and tracking IP assignments across offices. It is still a pilot, but it points toward easier multi-country recordals, the step that so often lags behind in acquisitions, as we discussed in IP Due Diligence in M&A. In the meantime, recording assignments promptly in each office remains essential.
Requiring US counsel adds cost, and international applicants should budget for it. But for companies serious about the US market, it is an opportunity to make the US filings strategic rather than an afterthought. A registered US practitioner can align claim drafting with US-specific issues such as Section 101 eligibility — where the USPTO’s evidence-based approach rewards careful preparation, as explained in our Section 101 and SMEDs guide — and coordinate US prosecution with your filings in Europe and Asia.
The USPTO’s new representation rule brings the US into line with most major patent offices: if you are based abroad, you need a registered US practitioner to file and prosecute. The rule applies to existing applications and issued patents, turns on domicile rather than citizenship, and can be triggered by a single foreign co-owner. The risk of ignoring it is not an immediate rejection but quiet failures — ineffective papers, lost priority, missed deadlines. If you are an international company building a US portfolio, we can help you put compliant, strategic representation in place and coordinate it with your filings around the world.
Ready to protect your IP?
Book a free 15-minute strategy call with our team.
Book a Free Strategy CallDisclaimer: This article provides general information about IP strategy and should not be relied upon as legal advice. IP laws vary significantly by jurisdiction and every business situation is unique. Consult qualified counsel about your specific circumstances.